-+ 0.00%
-+ 0.00%
-+ 0.00%

ALVOTECH AND ADVANZ PHARMA RECEIVE MARKETING APPROVAL ACROSS THE EUROPEAN ECONOMIC AREA FOR GOBIVAZ®, A FIRST-IN-MARKET BIOSIMILAR TO SIMPONI® (GOLIMUMAB)

Reuters·11/20/2025 09:00:14

Please log in to view news